From: Identifying dysregulated pathways in cancers from pathway interaction networks
GEO accession number | Disease | Number of samples (Disease/Control) | Platform |
---|---|---|---|
GSE 4115 | Lung Cancer | 187 (97/90) | GPL96 (HG-U133A) |
GSE 6919 | Prostate Tumour | 128 (65/63) | GPL8300 (HG_U95Av2) |
GSE 15852 | Breast Tumour | 86 (43/43) | GPL96 (HG-U133A) |
GSE 16515 | Pancreatic Tumour | 52 (36/16) | GPL570 (HG-U133_Plus_2) |